Clinical Trial Update: A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

View source ↗

Summary

This document outlines an expanded access/compassionate use protocol for 131I-MIBG therapy. It targets patients with refractory neuroblastoma and metastatic phe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Pheochromocytoma

Drugs mentioned

• 131I-MIBG (metaiodobenzylguanidine)

Snippet

Sponsor: Northwell Health | Conditions: Neuroblastoma, Pheochromocytoma | Status: AVAILABLE